Traditional MedicareCoverageMedium impact
Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation Management
Medicare/CMS - NCD·Cardiology, Hematology, Family Medicine +1 more·National Coverage Determination
Effective date
Apr 14, 2026
We identified it
Jun 17, 2026
Summary
This is a National Coverage Determination for home PT/INR monitoring devices used by patients on anticoagulation therapy. The policy establishes Medicare coverage criteria for home testing equipment and supplies for patients managing blood clotting medications.
Action Required
By April 14, 2026: Billing team must review current home PT/INR monitoring claims to ensure they meet the updated National Coverage Determination criteria. Verify that all claims include proper documentation of anticoagulation therapy medical necessity and patient training requirements. Update billing procedures to align with NCD 190.11 requirements to prevent claim denials.